Want to join the conversation?
$CMCSA's 3Q15 consolidated CapEx increased 11% to $2.2Bil. This CapEx increase was driven by increased investments at Cable. $CMCSA returned $2.8Bil of capital to shareholders, up 111% vs. 3Q14, including dividend payments of $623MM and share repurchases of $2.2Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.